Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$864M |
| 2 |
Shopify
SHOP
|
+$624M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$502M |
| 4 |
TSMC
TSM
|
+$470M |
| 5 |
Constellation Energy
CEG
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$843M |
| 3 |
Broadcom
AVGO
|
+$764M |
| 4 |
Amazon
AMZN
|
+$530M |
| 5 |
Uber
UBER
|
+$520M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Communication Services | 17.48% |
| 3 | Consumer Discretionary | 14.75% |
| 4 | Healthcare | 9.68% |
| 5 | Financials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Darden Restaurants
DRI
$23.6B
| $6.46M | ﹤0.01% |
29,655
+1,160
| +4% | +$241K |
|
402
Ivanhoe Electric
IE
$1.48B
| $6.27M | ﹤0.01% |
691,478
-14,238
| -2% | -$98.8K |
|
403
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
| $6.05M | ﹤0.01% |
142,692
+28,512
| +25% | +$1.19M |
|
404
Inspire Medical Systems
INSP
$1.5B
| $5.9M | ﹤0.01% |
45,439
-21,163
| -32% | -$3.07M |
|
405
Range Resources
RRC
$9.36B
| $5.72M | ﹤0.01% |
+140,643
| New | +$5.3M |
|
406
State Street SPDR S&P Metals & Mining ETF
XME
$3.88B
| $5.48M | ﹤0.01% |
81,590
-20,595
| -20% | -$1.22M |
|
407
Darling Ingredients
DAR
$9.55B
| $5.43M | ﹤0.01% |
143,137
-3,546
| -2% | -$117K |
|
408
Intuit
INTU
$87.9B
| $5.41M | ﹤0.01% |
6,871
+427
| +7% | +$289K |
|
409
Air Products & Chemicals
APD
$64.7B
| $5.31M | ﹤0.01% |
18,831
| – | – |
|
|
SLSR
410
Solaris Resources
SLSR
$1.25B
| $4.78M | ﹤0.01% |
1,043,391
-51,278
| -5% | -$208K |
|
|
OMDA
411
Omada Health Inc
OMDA
$1.22B
| $4.58M | ﹤0.01% |
+250,250
| New | +$4.33M |
|
412
American Express
AXP
$231B
| $4.51M | ﹤0.01% |
14,153
+4,401
| +45% | +$1.24M |
|
413
i3 Verticals
IIIV
$413M
| $4.4M | ﹤0.01% |
+160,259
| New | +$4.02M |
|
|
AKRO
414
DELISTED
Akero Therapeutics
AKRO
| $4.1M | ﹤0.01% |
76,863
+63,685
| +483% | +$2.89M |
|
415
ASML
ASML
$627B
| $3.84M | ﹤0.01% |
4,796
-4,720
| -50% | -$3.39M |
|
|
CHYM
416
Chime Financial
CHYM
$9.14B
| $3.77M | ﹤0.01% |
+109,116
| New | +$3.6M |
|
417
Applied Materials
AMAT
$404B
| $3.61M | ﹤0.01% |
19,730
+4,686
| +31% | +$743K |
|
418
iShares MSCI India ETF
INDA
$6.6B
| $3.6M | ﹤0.01% |
+64,679
| New | +$3.46M |
|
|
BA.PRA
419
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.04B
| $3.4M | ﹤0.01% |
50,000
| – | – |
|
420
Bunge Global
BG
$20.3B
| $3.24M | ﹤0.01% |
40,325
-41,972
| -51% | -$3.3M |
|
421
Solventum
SOLV
$15.1B
| $3.08M | ﹤0.01% |
+40,554
| New | +$2.87M |
|
422
MoonLake Immunotherapeutics
MLTX
$1.49B
| $2.94M | ﹤0.01% |
+62,318
| New | +$2.54M |
|
423
Gartner
IT
$10.1B
| $2.94M | ﹤0.01% |
7,274
-73,546
| -91% | -$30.8M |
|
424
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $2.8M | ﹤0.01% |
59,079
-425,399
| -88% | -$19.3M |
|
425
Canadian Pacific Kansas City
CP
$78.3B
| $2.65M | ﹤0.01% |
33,386
-5,919
| -15% | -$455K |
|
Similar funds
Jennison Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Jennison Associates held 642 positions worth $169B, up 18% from $143B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates's Q2 2025 filing shows 75 new, 257 increased, 235 reduced and 68 closed positions. Its largest new stake was Thermo Fisher Scientific: 165,992 shares worth $67.3M. The largest sale was Netflix, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Jennison Associates's largest Q2 2025 buy was Thermo Fisher Scientific: 165,992 shares worth $67.3M.
- Jennison Associates added most to Microsoft in Q2 2025, an estimated $864M increase.
- Jennison Associates's biggest Q2 2025 reduction was Netflix, cutting an estimated $1.03B.
- Jennison Associates fully exited Vertiv in Q2 2025, selling an estimated $308M.
- Jennison Associates's ten largest holdings make up 45% of its $169B portfolio in Q2 2025.
- Jennison Associates opened 75 new positions and closed 68 in Q2 2025.
- Jennison Associates's portfolio value rose 18% quarter-over-quarter to $169B.
Based on Jennison Associates's 13F filing for Q2 2025, filed 1 Aug 2025.